These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10589952)

  • 1. Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry.
    Scornik JC; Zander DS; Baz MA; Donnelly WH; Staples ED
    Transplantation; 1999 Nov; 68(10):1542-6. PubMed ID: 10589952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation.
    Itescu S; Tung TC; Burke EM; Weinberg A; Moazami N; Artrip JH; Suciu-Foca N; Rose EA; Oz MC; Michler RE
    Circulation; 1998 Aug; 98(8):786-93. PubMed ID: 9727549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques.
    Piazza A; Poggi E; Borrelli L; Servetti S; Monaco PI; Buonomo O; Valeri M; Torlone N; Adorno D; Casciani CU
    Transplantation; 2001 Apr; 71(8):1106-12. PubMed ID: 11374411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies.
    Masson E; Stern M; Chabod J; Thévenin C; Gonin F; Rebibou JM; Tiberghien P
    J Heart Lung Transplant; 2007 Jun; 26(6):642-5. PubMed ID: 17543791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of liver allografts to high or low concentrations of preformed antibodies as measured by flow cytometry.
    Scornik JC; Soldevilla-Pico C; Van der Werf WJ; Hemming AW; Reed AI; Langham MR; Howard RJ
    Am J Transplant; 2001 Jul; 1(2):152-6. PubMed ID: 12099363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of flow cytometry crossmatching in heart transplantation.
    Bishay ES; Cook DJ; Starling RC; Ratliff NB; White J; Blackstone EH; Smedira NG; McCarthy PM
    Eur J Cardiothorac Surg; 2000 Apr; 17(4):362-9. PubMed ID: 10773556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
    Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immunological relevance of antibodies in solid organ transplantation.
    Mehra NK; Baranwal AK
    Int J Immunogenet; 2016 Dec; 43(6):351-368. PubMed ID: 27870356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of flow cytometry to define unacceptable HLA antigens in lung transplant recipients with HLA-specific antibodies.
    Appel JZ; Hartwig MG; Cantu E; Palmer SM; Reinsmoen NL; Davis RD
    Transplantation; 2006 Apr; 81(7):1049-57. PubMed ID: 16612283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equal overall rejection rate in pre-transplant flow-cytometric cross-match negative and positive adult recipients in liver transplantation.
    Matinlauri IH; Höckerstedt KA; Isoniemi HM
    Clin Transplant; 2005 Oct; 19(5):626-31. PubMed ID: 16146554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HLA antibody analysis and crossmatching in heart and lung transplantation.
    Reinsmoen NL; Nelson K; Zeevi A
    Transpl Immunol; 2004; 13(1):63-71. PubMed ID: 15203130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.
    Bachelet T; Martinez C; Del Bello A; Couzi L; Kejji S; Guidicelli G; Lepreux S; Visentin J; Congy-Jolivet N; Rostaing L; Taupin JL; Kamar N; Merville P
    Transplantation; 2016 Jan; 100(1):159-66. PubMed ID: 26262501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of preformed IgG and IgM antibodies against donor endothelial progenitor cells in recipients of living donor kidney grafts.
    Daniel V; Sadeghi M; Suesal C; Scherer S; Tran H; Gombos P; Trojan K; Morath C; Opelz G
    Clin Transplant; 2016 Feb; 30(2):124-30. PubMed ID: 26537026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.
    Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM
    Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.